The Exchange has sought clarification from Dr Reddys Laboratories Ltd on September 17, 2026, with reference to news appeared in https://pharma.economictimes.indiatimes.com/ dated September 17, 2026 quoting \Dr Reddy's gets voluntary licence for Gilead's once-yearly HIV prevention drug\
The reply is awaited.